000			01398nam a2200121Ia 4500
008			220620s9999||||xx |||||||||||||| ||und||
245		0	_aArteriogenesis and Therapeutic Neovascularization
546			_aEnglish[eng]
650			_afactor VII activating protease||HABP2||VEGF||matrigel||neo-vascularization||hind limb ischemia||angiogenesis||arteriogenesis||ERK||endothelial cells||inflammation||macrophages||atherosclerosis||pericyte||rAAV||capillary||microRNA||isomiRs||epitranscriptome||neovascularization||A-to-I editing||m6A||RNA modifications||RNA methylation||lower extremity arterial disease||peripheral arterial disease||blood flow restriction||activity-based benefits||training effects||effect mechanism||hyperoxygenation||vein graft disease||vascular biology||spinal cord ischemia||paraplegia||aortic disease||TAAA||collateral network||paraspinous compartment||NO||NOTCH||innate immunity||mast cell||GH and eNOS||IGF-I||oxidative stress and arterial inflammation||vascular homeostasis||GHAS trial||collateral artery growth||SMC proliferation||potassium channel||KV1.3||KCa3.1||FGFR-1||Egr-1||PDFG-R||αSM-actin||TLR2/6||femoral artery ligation||blood flow recovery||collateral growth||VHL loss of function||microRNA-212/132||n/a
700			_aDeindl, Elisabeth||Quax, Paul||Waltenberger, Johannes||Schmitz-Rixen, Thomas
856			_uhttps://mdpi.com/books/pdfview/book/3044
942			_cEB
999			_c28886 _d28886